ExecPay

Nivalis Therapeutics

  • Pharmaceutical Preparations
  • Seattle, Washington

Compensation history

Top executives at Nivalis Therapeutics received an average of $1M per person in annual compensation from 2014 to 2021.

Average pay of disclosed executives at Nivalis Therapeutics
201420152016201720182019202020210600K1.2M1.8M2.4M
  • Salary
  • Options
  • Non-Equity Incentive
  • Bonus
  • Other

By year

Executives

We found eight executives who work or worked at Nivalis Therapeutics.

Mitchell Gold

Nivalis Therapeutics

Chief Executive Officer

6

Stanford Peng

Nivalis Therapeutics

President and Head of Research and Development

6

Paul Rickey

Nivalis Therapeutics

Chief Financial Officer

5

Zelanna Goldberg

Nivalis Therapeutics

Chief Medical Officer

1

Mark Litton

Nivalis Therapeutics

Chief Operating Officer

1

R Carruthers

Nivalis Therapeutics

Chief Financial Officer

3

Jon Congleton

Nivalis Therapeutics

Chief Executive Officer

3

Janice Troha

Nivalis Therapeutics

Chief Operating Officer

4

News

About Nivalis Therapeutics

  • Industry classifications
  • Division
    Manufacturing
    • Major group
      Chemicals And Allied Products
      • Industry group
        Drugs
        • Industry
          Pharmaceutical Preparations
  • Address
    188 East Blaine St., Suite 200, Seattle, Washington 98102
  • Phone
    206-788-4545
  • Fiscal year end
    December 31
  • Former names
  • Nivalis Therapeutics, Inc.
    Until July 25, 2017
  • N30 Pharmaceuticals, Inc.
    Until November 25, 2014
Source: SEC filings on April 29, 2022, May 5, 2020, April 24, 2019, April 24, 2018, and March 21, 2016.
0